Healthy Skepticism Library item: 3990

Warning: This library includes all items relevant to health product marketing that we are aware of regardless of quality. Often we do not agree with all or part of the contents.

Publication type: Journal Article

MaLAM letter follow up—Abbott
MaLAM Newsletter 1989 Feb; 1

Abstract:

Abbott has failed to provide any evidence for the usefulness of its combination product erythromycin with bromhexine.

Keywords:
*analysis/Philippines/developing countries/Abbott/erythromycin/bromhexine/antibiotics/company responses/quality of information/MaLAM/Medical Lobby for Appropriate Marketing/ATTITUDES REGARDING PROMOTION: INDUSTRY/PROMOTION AND HEALTH NEEDS: PROMOTION IN DEVELOPING COUNTRIES/REGULATION, CODES, GUIDELINES: FEEDBACK TO COMPANIES